The global clinical decision support systems market is expected to reach USD 1,752.0 million by 2023 from an estimated USD 1,001.9 million in 2018, growing at a CAGR of 11.8%. Growth in the clinical decision support systems market can primarily be attributed to government support & initiatives, growing incidence of medication errors, rising prominence & usage of big data and mhealth tools, high returns on investment for CDSS solutions, and growing adoption of cloud computing in healthcare are driving the growth of this market.
Download PDF Brochure @ https://www.marketsandmarkets.com/pdfdownload.asp?id=18085342
Product deployments; product launches, enhancements, and integrations; agreements, collaborations, and partnerships; acquisitions; and expansions were some of the strategies adopted by players from 2014 and 2018. The key players that adopted these strategies include Cerner Corporation (US), McKesson Corporation (US), Epic Systems Corporation (US), MEDITECH (US), Philips Healthcare (Netherlands), Wolters Kluwer Health (US), Hearst Health (US), Elsevier B.V. (Netherlands), International Business Machines (IBM) (US), and Allscripts Healthcare Solutions, Inc. (US).
Wolters Kluwer Health is the leading player in the clinical decision support systems market. The company offers a wide range of CDSS solutions. The company has a prominent position in the market owing to its large customer base and user-friendly solutions. The firm’s standalone CDSS solutions and integrated CDSS solutions provide informed and updated information to its end users. The company has a presence in more than 180 countries which include the US, the Netherlands, Brazil, Germany, Italy, France, Belgium, and the UK.
Zynx Health is another major player operating in the clinical decision support systems market. The company has empowered thousands of healthcare organizations and clinicians to align their clinical decision support, strategies, and workflows around the standardization and infusion of evidence-based vital information and experience-based best practices. The company has a prominent presence in the US and serves more than 1,700 hospitals. The company caters to the needs of physicians, nurses, and clinicians with evidence-based decision support.
Elsevier is one of the leading players in the clinical decision support systems market. The company has over 100 years of experience in providing its customers with advanced CDSS solutions and services. The firm is a part of RELX Group plc, a provider of information solutions for professional customers across industries. The company focuses on organic strategies like agreements, collaborations, and partnerships to enhance its foothold in the market. These strategies enable Elsevier to offer new features and updates to its customers. For instance, in 2018, VHL Alliance (VHLA) (US) collaborated with Elsevier to provide new content and module on Von Hippel-Lindau (VHL) disease.
Some of the other players competing in this market include Cerner Corporation (US), McKesson Corporation (US), Epic Systems Corporation (US), MEDITECH (US), Philips Healthcare (Netherlands), International Business Machines (IBM) (US), and Allscripts Healthcare Solutions, Inc. (US).
